The Yong Loo Lin School of Medicine, National University of  Singapore (NUS Medicine), and 22Health Ventures, an early-stage healthtech investment firm, have announced their joint accelerator programme, NUS Medicine Digital Advanced  Technology Accelerator (DATA), an NUS Medicine – 22Health Ventures partnership.

Applications are open for the first cohort of early-stage startup participants in  the Accelerator, with the 11-week programme for the cohort launching in late-September 2024. 

The objective of the Accelerator is to promote the development of promising ideas in digital  healthcare and translate these into thriving businesses that elevate personal health and well being. The current scope of the Accelerator involves identifying and developing companies  focused on digital health from Singapore and across Southeast Asia.

NUS Medicine and 22Health  Ventures are aligned on accelerating healthtech successes through digital empowerment, market  access to achieve global competitiveness and opportunities for funding. 

The Accelerator is focused on sourcing Singapore and Southeast Asian startups, including through hack-a-thons (such  as NUS Medicine HealthHack); engaging with participants, in formal and informal sessions, over a 11-week period to allow  entrepreneurs needed time to study, learn and evolve; offering workshops and other programmes across a wide range of components, including  global entrepreneurship and business building skills, intellectual property, fundraising,  business and financial models, market education and legal and regulatory matters.

It will also focus on making introductions to clinicians, payor experts and other industry professionals for  problem-solution fit, clinical validation and market viability in Singapore and the US.